Investors / filer profile

Taylor Andrew Lawrence

Chief Financial Officer

active in 1 company · 1 of 1 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 10
Filings: 1
Companies: 2026-08-26
Last filed

EDGAR · CIK 0001723889 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+47.7%

median move per position

+6.3%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$5.1K bought

All filings on record

Every Form 4 transaction we track for this filer


OBIOOrchestra BioMed Holdings, Inc.	Tax $16.2K · 3,076 sh	2026-08-26	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $12.2K · 3,076 sh	2026-05-28	—
OBIOOrchestra BioMed Holdings, Inc.	Grant — · 181,000 sh	2026-02-12	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $14.9K · 3,452 sh	2026-01-02	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $40.5K · 8,670 sh	2025-12-10	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $16.4K · 3,071 sh	2025-11-25	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $39.6K · 16,102 sh	2025-09-17	—
OBIOOrchestra BioMed Holdings, Inc.	Buy $5.1K · 2,000 sh	2025-08-25	—
OBIOOrchestra BioMed Holdings, Inc.	Grant — · 80,000 sh	2025-08-07	—
OBIOOrchestra BioMed Holdings, Inc.	Tax $88.5K · 28,172 sh	2025-06-11	—

OBIOTax

2026-08-26 · Orchestra BioMed Holdings, Inc.

$16.2K

—

OBIOTax

2026-05-28 · Orchestra BioMed Holdings, Inc.

$12.2K

—

OBIOGrant

2026-02-12 · Orchestra BioMed Holdings, Inc.

181,000

—

OBIOTax

2026-01-02 · Orchestra BioMed Holdings, Inc.

$14.9K

—

OBIOTax

2025-12-10 · Orchestra BioMed Holdings, Inc.

$40.5K

—

OBIOTax

2025-11-25 · Orchestra BioMed Holdings, Inc.

$16.4K

—

OBIOTax

2025-09-17 · Orchestra BioMed Holdings, Inc.

$39.6K

—

OBIOBuy

2025-08-25 · Orchestra BioMed Holdings, Inc.

$5.1K

—

OBIOGrant

2025-08-07 · Orchestra BioMed Holdings, Inc.

80,000

—

OBIOTax

2025-06-11 · Orchestra BioMed Holdings, Inc.

$88.5K

—

10 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.